International Journal of Clinical Oncology, published by SPRINGER JAPAN KK, is a leading peer-reviewed journal dedicated to advancing research and clinical practices in the fields of oncology, hematology, and surgery. With its impact factor reflecting its significance and reach in the academic community, this journal serves as a solid platform for researchers, professionals, and students to share and disseminate groundbreaking discoveries and methodologies. Notably, it has secured prestigious rankings in the Q1 category in Medicine (miscellaneous) and Surgery, and Q2 in Hematology and Oncology, illustrating its prominent position in the medical literature. The journal's comprehensive scope addresses pivotal clinical issues from 1996 through 2024, further solidifying its relevance in the ever-evolving landscape of cancer research. Despite not offering open access, the depth and quality of research articles ensure that vital information remains accessible to those committed to improving clinical outcomes in oncology. With a focus on innovative treatments and patient care, the International Journal of Clinical Oncology embodies a commitment to fostering excellence in medical research.

The JOURNAL OF SURGICAL ONCOLOGY, published by Wiley, stands as a pivotal resource for medical professionals, researchers, and students engaged in the fields of surgery and oncology. Established in 1969, this esteemed journal covers a diverse range of topics related to the surgical management of cancer, supporting advancements in treatment protocols and patient care. With a Q1 ranking in Surgery and Q2 rankings in both Medicine and Oncology for 2023, it holds a prominent position in the academic landscape, underscoring its impact in enhancing surgical techniques and oncological research. Researchers looking to disseminate their findings will benefit from the journal's rigorous peer-review process and commitment to publishing high-quality content that drives innovation in the field. For access, readers will find both print and online formats available, making vital research accessible to a broad audience committed to improving surgical oncology practice.

Medicina Oral Patologia Oral y Cirugia Bucal, published by MEDICINA ORAL S L, is a premier journal that caters to the fields of dentistry, medicine, otorhinolaryngology, and surgery. With its ISSN 1698-6946, this esteemed publication has made significant strides in disseminating high-quality research since its inception in 2004, continuing to contribute to the body of knowledge through 2024. Recognized for its impactful contributions, the journal proudly holds a Q1 ranking in Dentistry and significant Q2 rankings in Medicine and Otorhinolaryngology categories for the year 2023. Its impressive Scopus rankings position it among the top journals, with a notable 80th percentile for Medicine & Surgery and Otorhinolaryngology. The journal aims to bridge the gap between academic research and practical application, serving as an essential resource for researchers, healthcare professionals, and students alike. This commitment to excellence ensures that Medicina Oral Patologia Oral y Cirugia Bucal remains a vital platform for the advancement of clinical practices and innovations within its diverse scope.

Molecular and Clinical Oncology is a dynamic journal published by SPANDIDOS PUBL LTD, aimed at advancing the understanding of cancer biology and treatment modalities. With an ISSN of 2049-9450 and an E-ISSN of 2049-9469, the journal serves as a critical platform for researchers and clinicians dedicated to uncovering novel insights in molecular oncology and enhancing clinical practices. As a testament to its growing influence, the journal has achieved a Q3 ranking in Oncology and a Q4 ranking in Cancer Research for the year 2023, reflecting its commitment to publishing high-quality research. Although currently not an Open Access publication, the journal offers crucial subscription options, ensuring comprehensive access to groundbreaking studies and innovations in the field. With converged years spanning 2018 to 2024, the journal is set to continue enriching the academic community with its valuable contributions, ultimately empowering researchers, professionals, and students engaged in the fight against cancer.

SEMINARS IN RADIATION ONCOLOGY is a premier journal published by W B SAUNDERS CO-ELSEVIER INC, dedicated to advancing the field of radiation oncology through high-quality research and comprehensive reviews. With an impressive impact factor and a notable HIndex, this journal holds a prominent place within the academic community, particularly illustrated by its Q2 ranking in both Cancer Research and Oncology, and a Q1 ranking in Radiology, Nuclear Medicine, and Imaging as of 2023. Since its inception in 1991, the journal has served as a vital resource for researchers, clinicians, and healthcare professionals, facilitating the exchange of innovative ideas and practices that shape the future of cancer treatment. While the journal is not open access, it offers essential insights into the latest advancements in the field, catering to a diverse audience eager to expand their knowledge and improve patient outcomes in the realm of radiation therapy.

Clinical Lung Cancer is a prestigious journal published by CIG MEDIA GROUP, LP, dedicated to advancing the field of oncology and pulmonary medicine since its establishment in 2000. With an impressive impact factor and high ranking within its fields—achieving Q1 status in Oncology and Pulmonary and Respiratory Medicine in 2023—this journal serves as a vital resource for researchers, clinicians, and students alike. Covering a wide scope of topics related to lung cancer, Clinical Lung Cancer offers a platform for innovative studies, clinical trials, and comprehensive reviews that contribute to both theory and practice. While it operates on a subscription basis, the quality of content is reflected in its ranked status within the top quartile of cancer research journals. This journal plays a critical role in shaping the future of lung cancer research and treatment, making it an essential destination for those looking to stay at the forefront of the field.

Oral Science International is a distinguished academic journal published by WILEY, focusing on the multidisciplinary field of otorhinolaryngology. With an ISSN of 1348-8643 and an E-ISSN of 1881-4204, this journal serves as a vital resource for researchers, professionals, and students interested in the latest developments and innovations in oral and maxillofacial sciences. Established over two decades ago, it has steadily built a solid reputation within the scientific community, currently holding a Q3 ranking in the 2023 Otorhinolaryngology category and ranking #77 out of 123 on the Scopus scale, placing it in the 37th percentile. Although it is not an Open Access journal, Oral Science International continues to provide pivotal insights that drive research and professional practice forward. Located in Japan, this journal emphasizes the importance of global collaboration and knowledge sharing in advancing oral health care and associated disciplines.

Head & Neck Pathology is a leading journal dedicated to advancing the study of pathologies affecting the head and neck region, published by Springer. With an ISSN of 1936-055X and E-ISSN of 1936-0568, this journal serves as a vital resource for the dissemination of research in oncology, otorhinolaryngology, and pathology, achieving impressive rankings of Q2 in Oncology and Q1 in both Otorhinolaryngology and Pathology & Forensic Medicine in 2023. Since its inception in 2007, Head & Neck Pathology has continued to provide a platform for innovative research findings, case studies, and reviews, fostering a deeper understanding of head and neck diseases. The journal's commitment to excellence is reflected in its rigorous peer-review process and accessibility through various academic platforms. Researchers, clinicians, and students will find valuable insights and knowledge that can enhance clinical practice and improve patient outcomes in the dynamic field of head and neck pathology.

INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY is a premier peer-reviewed journal published by Churchill Livingstone, dedicated to advancing the field of oral and maxillofacial surgery. With an impressive Q1 ranking in the categories of Oral Surgery, Otorhinolaryngology, and Surgery as of 2023, this journal serves as a vital resource for researchers, clinicians, and students alike, offering cutting-edge research findings, clinical studies, and innovative surgical techniques. The journal covers a wide range of topics within its scope, ensuring that it remains at the forefront of advancements in surgical practice and patient care. Though it operates under a traditional access model, its Impact Factor reflects its significance in the field and its role in disseminating critical knowledge. Established in 1986, the INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY continues to be an essential tool for those dedicated to enhancing therapeutic outcomes and surgical methodologies, solidifying its position as a trusted resource in the ongoing evolution of maxillofacial sciences.

Journal of Oral and Maxillofacial Surgery Medicine and Pathology, published by Elsevier Science Inc, serves as a vital resource in the multidisciplinary field of oral and maxillofacial surgery, pathology, and related medical disciplines. With an ISSN of 2212-5558 and an E-ISSN of 2212-5566, this journal plays a pivotal role in advancing knowledge and practices from 2012 to 2024. Recognized for its rigorous peer-review process and quality contributions, it has achieved notable rankings in various categories, including Q3 in Oral Surgery and Q3 in Otorhinolaryngology as of 2023. Although the journal does not currently offer an open access option, it remains a key platform for publishing innovative research that enhances patient care and surgical techniques. This journal is an essential read for researchers, clinicians, and students dedicated to the fields of dentistry, pathology, and surgical medicine, ensuring that they remain at the forefront of community advancements and clinical developments.